American researchers have presented a new way to treat Alzheimer's disease. This may be effective in the early stages of the disease.
Neurodegenerative diseases cause nerve cells in the brain to gradually lose their function and die. The most famous of these diseases are Parkinson's disease, amyotrophic lateral sclerosis (ALS), and Parkinson's disease. Alzheimer's disease, which affects women more than men. And in Germany, according to German Alzheimer's Association About 1.8 million people suffer from dementia, the majority of whom suffer from Alzheimer's disease. Although there are various treatment methods aimed at halting the progression of the disease, there is still no cure for Alzheimer's disease. A research team from the USA has now presented a new treatment method that is said to be effective in the early stages of the disease. The results were published in the specialized journal iScience published.
Don't miss out: you can find everything related to health in the regular newsletter sent by our health experts on the 24vita.de website.
A new approach to treating dementia? Researchers are examining other possibilities
In the latest research group led by Scott Selleck of Pennsylvania State University He studies Identify a group of proteins that may be involved in the development of neurological disease. These protein building blocks could be responsible for the unusual buildup of proteins in brain cells. Accumulations, in turn, can disrupt the breakdown processes in brain cells and lead to the formation of so-called plaques. These deposits disrupt the faulty communication between nerve cells that is typical of dementia and hinder the supply of nutrients.
These accumulations have been previously observed in previous studies. However, it was previously unclear what role they play in disease development. By studying human cells and brain cells from mice with Alzheimer's dementia, researchers in the current study were able to show the relationship between protein accumulations and the development of various neurodegenerative diseases.
More research is needed for new Alzheimer's treatment approaches
“In the early stages of many neurodegenerative diseases, cellular degeneration is impaired, meaning cells have less repair capacity,” Scott Sellick, a professor of biochemistry and molecular biology at Penn State Eberly College of Science, said in a press release. According to Slick, the new treatment approach could be effective in the early stages of the disease.
However, Katherine Gray, chief of research at the Alzheimer's Association of America, stresses that more research is needed. “Since the processes have only been demonstrated in fruit flies and human cells outside the brain, it is difficult to say how significant the findings are at this time. We look forward to the next phase of this research to see whether similar effects can be observed in human brain cells.” Medical news today.
This article only contains general information about the health topic in question and is therefore not intended for self-diagnosis, treatment or medication. It does not, in any way, replace a visit to a doctor. Our editorial team is not permitted to answer individual questions about medical conditions.
“Total coffee aficionado. Travel buff. Music ninja. Bacon nerd. Beeraholic.”
More Stories
Exploding Fireball: Find the meteorite fragments
Neuralink's competitor lets blind people see again with an implant
A huge meteorite has hit Earth – four times the size of Mount Everest